US FDA rejects EUA for Covaxin

US FDA rejects EUA for Covaxin

Newsdesk |
June 11, 2021

The US’ Food and Drug Administration (FDA) on Friday rejected emergency use authorisation for Bharat Biotech’s Covaxin vaccine, instead recommending that the vaccine manufacturer’s US partner apply for biologics licence application (BLA), PTI reported. BLA is a “full approval” mechanism by the FDA for drugs and vaccines.

New Delhi, 11 June 2021

As per news report of The Indian Express, India reported 91,702 new coronavirus cases in the last 24 hours, with which the country’s caseload rose to over 2.9 crore. The death toll surged to more than 3.7 lakh after 3,403 Covid-related deaths were recorded on Thursday. Tamil Nadu remains the highest contributor with 16,813 cases. Active cases have dropped further to 11.21 lakh.



If you like the story and if you wish more such stories, support our effort Make a donation.


If you believe investigative journalism is essential to making democracy functional and accountable support us. »